Investing Insights

Alphabet's New Model & Novo's Lawsuit

Analysis of Alphabet's Gemini model reception, the legal battle between Novo Nordisk and Eli Lilly, and GE Vernova's stock performance.

The episode discusses Alphabet's new Gemini model, which has received mixed reactions, alongside Novo Nordisk's lawsuit against Eli Lilly and GE Vernova's stock falling despite strong earnings.

1
20 minJul 22, 2026Motley Fool Hidden Gems Investing

Listen to the source episode

Alphabet’s New Model & Novo’s Lawsuit

Continue in GenPod

Turn this episode into your next question.

Ask naturally. GenPod can find a related episode—or make a focused explainer when the right one does not exist.
Join the beta

Key takeaways

What to know before you press play.

01

Gemini Model Reception

A new Gemini model has been released, but the AI world is not particularly impressed, raising questions about Alphabet's strategic positioning.

13
02

Alphabet's Strategic Position

The discussion explores whether Alphabet is demonstrating superior business acumen or experiencing a loss of its competitive magic.

1
03

Novo Nordisk vs. Eli Lilly

Novo Nordisk has filed a lawsuit against Eli Lilly, a move interpreted as a sign of desperation within the pharmaceutical sector.

156
04

GE Vernova Earnings

GE Vernova's stock fell following a strong earnings report, prompting analysis of the energy sector's potential peak.

178

Ask GenPod next

Keep the question moving.

01

What are the specific details of the lawsuit between Novo Nordisk and Eli Lilly?

02

How does the reception of the new Gemini model compare to previous AI releases?

03

What factors contributed to GE Vernova's stock falling despite strong earnings?

Background reading

The context behind the episode.

Market Context

Companies Discussed

The episode covers GE Vernova (GEV), Alphabet (GOOG), Novo Nordisk (NVO), and Eli Lilly (LLY).

9

Questions

Questions to carry into the episode.

How is the AI world reacting to the new Gemini model?

The AI world is not impressed with the new Gemini model.

1
What is the nature of the conflict between Novo Nordisk and Eli Lilly?

Novo Nordisk is suing Eli Lilly, a move described as stemming from desperation.

156
What happened to GE Vernova's stock after its earnings report?

GE Vernova's stock fell after a great earnings report.

17
Who are the hosts and guests on this episode?

The hosts are Travis Hoium, Lou Whiteman, and Jon Quast.

21011

Experts

Voices named in the source.

Travis Hoium

Host

10

Lou Whiteman

Guest

11

Jon Quast

Guest

11

Sources and disclosure

Where this guide comes from.

Ads are sponsored content. TMF does not endorse or verify ad statements. TMF is not involved in the offer or sale of advertised securities. Investors should conduct due diligence and consult advisors. TMF assumes no responsibility for losses. Opinions are the Fools' own. Products were loaned or purchased. Advertisers paid for sponsorship.

  1. Publisher show notes

    A new Gemini model is out and the AI world isn’t impressed. But is this Alphabet knowing its business better than anyone else or a loss of the company’s magic? Plus, we discuss Novo Nordisk suing Eli Lilly and GE Vernova’s stock falling after a great earnings report.

  2. Publisher show notes

    Travis Hoium, Lou Whiteman, and Jon Quast discuss:

  3. Publisher show notes

    - Gemini’s Model Dud?

  4. Publisher show notes

    - Gemini Pro Delay

  5. Publisher show notes

    - Novo Sues Eli Lilly

  6. Publisher show notes

    - Novo’s Desperation

  7. Publisher show notes

    - GE Vernova Earnings

  8. Publisher show notes

    - Energy’s Peak

  9. Publisher show notes

    Companies discussed: GE Vernova (GEV), Alphabet (GOOG), Novo Nordisk (NVO), Eli Lilly (LLY).

  10. Publisher show notes

    Host: Travis Hoium

  11. Publisher show notes

    Guests: Lou Whiteman, Jon Quast

  12. Publisher show notes

    Engineer: Dan Boyd

  13. Publisher show notes

    Disclosure: Advertisements are sponsored content and provided for informational purposes only.

  14. Publisher show notes

    The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements.

  15. Publisher show notes

    TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented.

  16. Publisher show notes

    Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions.

  17. Publisher show notes

    TMF assumes no responsibility for any losses or damages arising from this advertisement.

  18. Publisher show notes

    We’re committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode.

  19. Publisher show notes

    Learn more about your ad choices. Visit ⁠⁠⁠megaphone.fm/adchoices

  20. Publisher show notes

    Learn more about your ad choices. Visit megaphone.fm/adchoices

Related listening guides

Choose what to hear next.